Furthermore, administration of tirabrutinib to the KrasG12D orthotopic mouse model reduced tumor cell growth and infiltrating regulatory B cells with increasing numbers of CD8+IFNγ+ T cells, thus also indicating BTK’s role in immune function [41]. Here, CD8A is linked to neoplasm.